CAC
EXEL icon

Cowen and Company’s Exelixis EXEL Stock Holding History

Cowen and Company’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,000
Closed -$22K – 125
2024
Q3 		$22K Hold
29,000
– – ﹤0.01% 421
2024
Q2 		$52.9K Sell
29,000
-43,000
-60% -$954K ﹤0.01% 311
2024
Q1 		$36.8K Buy
+72,000
New +$1.6M ﹤0.01% 379
2023
Q4 		– Sell
-126,300
Closed -$101K – 618
2023
Q3 		$101K Buy
+126,300
New +$2.64M 0.01% 251
2021
Q3 		– Sell
-27,500
Closed -$125K – 636
2021
Q2 		$125K Buy
+27,500
New +$641K 0.01% 322
2021
Q1 		– Sell
-15,000
Closed -$22K – 565
2020
Q4 		$22K Buy
+15,000
New +$314K ﹤0.01% 316

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cowen and Company's EXEL Position: Q4 2024 in Review

Cowen and Company sold out of Exelixis (EXEL) in Q4 2024, closing a stake of 362 shares — an estimated $9.39K sold.

Cowen and Company first reported a position in EXEL in Q4 2020 and held it in 4 quarters. The position peaked at $2.22M in Q4 2023. 519 funds tracked by Wall St. Rank hold EXEL as of Q4 2024.

  • Cowen and Company reported no remaining Exelixis position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 362 Exelixis shares in Q4 2024, an estimated $9.39K.
  • Cowen and Company first reported a position in Exelixis in Q4 2020 and held it in 4 quarters.
  • Cowen and Company's Exelixis position peaked at $2.22M in Q4 2023.
  • 519 funds tracked by Wall St. Rank held Exelixis as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.